Insider selling
Traded May 15, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Sanuwave Health's Chief Sci. and Tech. Officer sold $115K of Sanuwave Health shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Apr 29, 2025 · Filed Apr 30, 2025
A major shareholder of Sanuwave Health paid $76K out of pocket for Sanuwave Health shares. Shares held went up 25% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$76,421
Shares × reported transaction price
$25K–$100K
+25.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 5 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 5 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
21 days after results of Apr 8, 2025, 10 days before results of May 9, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +8.3% | +1.2% | +7.1% |
| 30 days | −9.9% | +6.1% | −16.1% |
| 90 days | +23.6% | +13.6% | +9.9% |
| 180 days | +6.6% | +23.0% | −16.5% |
| 365 days | −46.0% | +29.0% | −75.0% |
Past results only. Not a forecast.
Insider selling
Traded May 15, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Sanuwave Health's Chief Sci. and Tech. Officer sold $115K of Sanuwave Health shares. The filing does not indicate a pre-arranged trading plan.
Insider buying
Traded Apr 29, 2025 · filed 1 day later
A major shareholder of Sanuwave Health paid $127K out of pocket for Sanuwave Health shares.
Opaleye Management Inc., 10% owner's past purchases, 90 days after disclosure: 64 buys, median +3.2 pts vs S&P 500, beat it 36 of 64 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.